SCHEMBL4970583

SCHEMBL4970583

COC(C)(COC(c1cccc(Cl)c1)C1CCCN(C(=O)O)C1)OC

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
REN P00797 16/20 0.49
CYP3A4 P08684 3/20 0.49
CPT2 P23786 1/20 0.39
CPT1A P50416 1/20 0.39
CPT1B Q92523 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4970568 1.00 REN (0.49) RENCYP3A4CPT2CPT1ACPT1B
SCHEMBL3607433 0.90 REN (0.49) RENCYP3A4
SCHEMBL3607432 0.90 REN (0.49) RENCYP3A4
SCHEMBL3607435 0.90 REN (0.49) RENCYP3A4
SCHEMBL4973080 0.84 REN (0.57) RENCYP3A4
SCHEMBL4973087 0.84 REN (0.57) RENCYP3A4
SCHEMBL970983 0.82 REN (0.56) RENCYP3A4
SCHEMBL973594 0.82 REN (0.50) RENCYP3A4
SCHEMBL970985 0.82 REN (0.56) RENCYP3A4
SCHEMBL973596 0.82 REN (0.50) RENCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed